| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1995PNAS...92.3259T |
| P356 | DOI | 10.1073/PNAS.92.8.3259 |
| P8608 | Fatcat ID | release_wiyhepztk5cthbknxhkfjqplrm |
| P932 | PMC publication ID | 42145 |
| P698 | PubMed publication ID | 7724549 |
| P5875 | ResearchGate publication ID | 15473737 |
| P50 | author | Elliott D. Kieff | Q43399614 |
| P2093 | author name string | D Reinberg | |
| R Drapkin | |||
| X Tong | |||
| P2860 | cites work | p44 and p34 subunits of the BTF2/TFIIH transcription factor have homologies with SSL1, a yeast protein involved in DNA repair | Q24315493 |
| Purification, cloning, and characterization of a human coactivator, PC4, that mediates transcriptional activation of class II genes | Q24317228 | ||
| Transcription factor IIE binds preferentially to RNA polymerase IIa and recruits TFIIH: a model for promoter clearance | Q24322625 | ||
| The ERCC2/DNA repair protein is associated with the class II BTF2/TFIIH transcription factor | Q24595611 | ||
| Correction of xeroderma pigmentosum repair defect by basal transcription factor BTF2 (TFIIH) | Q24596052 | ||
| Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53 | Q24609153 | ||
| Structure and functional properties of human general transcription factor IIE | Q28115411 | ||
| Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II | Q28251866 | ||
| Transcription factors IIE and IIH and ATP hydrolysis direct promoter clearance by RNA polymerase II | Q28646845 | ||
| DNA repair helicase: a component of BTF2 (TFIIH) basic transcription factor | Q29619833 | ||
| Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product | Q29620442 | ||
| Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation | Q34324039 | ||
| Cloning of the 62-kilodalton component of basic transcription factor BTF2. | Q34338584 | ||
| The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter | Q34355226 | ||
| Human xeroderma pigmentosum group D gene encodes a DNA helicase | Q34358690 | ||
| Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. | Q34625121 | ||
| Structural motifs and potential sigma homologies in the large subunit of human general transcription factor TFIIE. | Q34989722 | ||
| Conserved sequence motifs in the small subunit of human general transcription factor TFIIE. | Q34989727 | ||
| The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein | Q35648541 | ||
| Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. | Q35829475 | ||
| The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein. | Q35830605 | ||
| The regulation of transcription by phosphorylation | Q36377421 | ||
| Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line | Q36507642 | ||
| The recombination signal sequence-binding protein RBP-2N functions as a transcriptional repressor | Q36652805 | ||
| EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus | Q36688330 | ||
| Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element | Q36797190 | ||
| Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. | Q36801839 | ||
| Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23 | Q36806063 | ||
| The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization | Q36806641 | ||
| Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. | Q36810617 | ||
| Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression | Q36828413 | ||
| Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye | Q36927515 | ||
| Mutational analysis of ERCC3, which is involved in DNA repair and transcription initiation: identification of domains essential for the DNA repair function | Q38307435 | ||
| Dual roles of a multiprotein complex from S. cerevisiae in transcription and DNA repair | Q38313225 | ||
| Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein. | Q40108807 | ||
| The xeroderma pigmentosum group B protein ERCC3 produced in the baculovirus system exhibits DNA helicase activity | Q40522217 | ||
| The multifunctional TFIIH complex and transcriptional control | Q40592872 | ||
| Regulation of TFIIH ATPase and kinase activities by TFIIE during active initiation complex formation | Q41481294 | ||
| Cell phenotype-dependent control of Epstein-Barr virus latent membrane protein 1 gene regulatory sequences | Q41543823 | ||
| Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes | Q43679392 | ||
| Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa | Q45781476 | ||
| Initiation of transcription by RNA polymerase II: a multi-step process. | Q52545755 | ||
| Factors involved in specific transcription by mammalian RNA polymerase II. Identification and characterization of factor IIH | Q55043488 | ||
| Transcription factor b (TFIIH) is required during nucleotide-excision repair in yeast | Q58318854 | ||
| Binding of general transcription factor TFIIB to an acidic activating region | Q59058683 | ||
| Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II | Q59098636 | ||
| Factors involved in specific transcription by mammalian RNA polymerase II. Purification and functional analysis of general transcription factor IIE | Q70146901 | ||
| An oligomeric form of the large subunit of transcription factor (TF) IIE activates phosphorylation of the RNA polymerase II carboxyl-terminal domain by TFIIH | Q72108281 | ||
| The function(s) of CAK, the p34cdc2-activating kinase | Q72545154 | ||
| Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV | Q72756611 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| molecular mass | Q182854 | ||
| P304 | page(s) | 3259-63 | |
| P577 | publication date | 1995-04-11 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2 | |
| P478 | volume | 92 |
| Q24524363 | A role for SKIP in EBNA2 activation of CBF1-repressed promoters |
| Q39642344 | An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter |
| Q24657618 | An interplay between TATA box-binding protein and transcription factors IIE and IIA modulates DNA binding and transcription |
| Q30981859 | BS69/ZMYND11 C-Terminal Domains Bind and Inhibit EBNA2. |
| Q33998709 | C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7. |
| Q40883667 | CKII site in Epstein-Barr virus nuclear protein 2 controls binding to hSNF5/Ini1 and is important for growth transformation |
| Q38341023 | Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation. |
| Q39682376 | Conserved region CR2 of Epstein-Barr virus nuclear antigen leader protein is a multifunctional domain that mediates self-association as well as nuclear localization and nuclear matrix association |
| Q28203672 | Defective interplay of activators and repressors with TFIH in xeroderma pigmentosum |
| Q39776571 | Differential hyperacetylation of histones H3 and H4 upon promoter-specific recruitment of EBNA2 in Epstein-Barr virus chromatin. |
| Q33851043 | Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection |
| Q35732134 | Direct interactions between Epstein-Barr virus leader protein LP and the EBNA2 acidic domain underlie coordinate transcriptional regulation |
| Q35862488 | EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein-Barr virus-transformed B lymphocytes |
| Q33850943 | EBNA-LP associates with cellular proteins including DNA-PK and HA95. |
| Q37093792 | EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance |
| Q38597233 | EBNA2 and Its Coactivator EBNA-LP. |
| Q37596895 | EBNA2 is required for protection of latently Epstein-Barr virus-infected B cells against specific apoptotic stimuli. |
| Q57186827 | EBNA2: A Viral Transcription Factor Essential for the Immortalization of Human B Lymphocytes by the Epstein-Barr Virus (EBV) |
| Q34465612 | EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth |
| Q42487093 | EBV EBNA 2 stimulates CDK9-dependent transcription and RNA polymerase II phosphorylation on serine 5. |
| Q34977875 | EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding |
| Q24540313 | Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2. |
| Q24681418 | Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1 |
| Q33850964 | Epstein-Barr virus nuclear protein 2 has at least two N-terminal domains that mediate self-association |
| Q37156071 | Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter |
| Q35014692 | Epstein-Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; only the NTD interaction is essential for lymphoblastoid cell growth |
| Q35891360 | Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation |
| Q35963272 | Epstein-Barr virus oncoprotein super-enhancers control B cell growth |
| Q33787090 | Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site |
| Q38289967 | Expression of transcription factor AML-2 (RUNX3, CBF(alpha)-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype |
| Q24649809 | Fos-Jun dimerization promotes interaction of the basic region with TFIIE-34 and TFIIF |
| Q38295122 | Functional cooperation of Epstein-Barr virus nuclear antigen 2 and the survival motor neuron protein in transactivation of the viral LMP1 promoter |
| Q35847090 | Functional interactions between p53 and the TFIIH complex are affected by tumour-associated mutations |
| Q45768039 | Glial and muscle embryonal carcinoma cell-specific independent regulation of expression of human JC virus early promoter by cyclic AMP response elements and adjacent nuclear factor 1 binding sites |
| Q28573627 | Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH |
| Q35839875 | Hsp72 up-regulates Epstein-Barr virus EBNALP coactivation with EBNA2 |
| Q34350537 | Identification and cloning of a novel chromatin-associated protein partner of Epstein-Barr nuclear protein 2. |
| Q36562751 | Identification of seven hydrophobic clusters in GCN4 making redundant contributions to transcriptional activation |
| Q36048657 | Importance of acidic, proline/serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: generation of transdominant-negative mutants |
| Q91709780 | Increased association between Epstein-Barr virus EBNA2 from type 2 strains and the transcriptional repressor BS69 restricts EBNA2 activity |
| Q39588351 | Intracellular forms of human NOTCH1 functionally activate essential Epstein-Barr virus major latent promoters in the Burkitt's lymphoma BJAB cell line but repress these promoters in Jurkat cells |
| Q37009375 | Mitosis-specific hyperphosphorylation of Epstein-Barr virus nuclear antigen 2 suppresses its function |
| Q34998243 | Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming |
| Q34225554 | Molecular virology of Epstein-Barr virus |
| Q41064467 | Opening of an RNA polymerase II promoter occurs in two distinct steps and requires the basal transcription factors IIE and IIH. |
| Q33604108 | Promoter-specific targeting of human SWI-SNF complex by Epstein-Barr virus nuclear protein 2. |
| Q28114910 | Protein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins |
| Q34064221 | RNA polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr virus |
| Q42509472 | Reconstitution of recombinant TFIIH that can mediate activator-dependent transcription |
| Q40471319 | Regulation of expression of the Epstein-Barr virus BamHI-A rightward transcripts. |
| Q33786088 | Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation. |
| Q40124399 | Role of a consensus AP-2 regulatory sequence within the Epstein-Barr virus LMP1 promoter in EBNA2 mediated transactivation |
| Q38331191 | Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genes |
| Q48364355 | Site-Specific Isotope-Labeling of Inosine Phosphoramidites and NMR Analysis of an Inosine-Containing RNA Duplex |
| Q47271015 | Species-specific functions of Epstein-Barr virus nuclear antigen 2 (EBNA2) reveal dual roles for initiation and maintenance of B cell immortalization. |
| Q27682610 | Structural and Functional Characterization of a Complex between the Acidic Transactivation Domain of EBNA2 and the Tfb1/p62 Subunit of TFIIH |
| Q33552252 | TFIIH operates through an expanded proximal promoter to fine-tune c-myc expression |
| Q38008913 | TFIIH: when transcription met DNA repair. |
| Q35664999 | The EBNA-2 N-Terminal Transactivation Domain Folds into a Dimeric Structure Required for Target Gene Activation |
| Q24329182 | The Epstein-Barr Virus Nuclear Protein 2 Acidic Domain Forms a Complex with a Novel Cellular Coactivator That Can Interact with TFIIE |
| Q42702063 | The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter |
| Q34275895 | The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis |
| Q28140020 | The FBP interacting repressor targets TFIIH to inhibit activated transcription |
| Q35859057 | The N-terminal half of EBNA2, except for seven prolines, is not essential for primary B-lymphocyte growth transformation. |
| Q28254616 | The cyclin-dependent kinase-activating kinase (CAK) assembly factor, MAT1, targets and enhances CAK activity on the POU domains of octamer transcription factors |
| Q33845947 | The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promoters |
| Q34034925 | The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells |
| Q39551287 | The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2. |
| Q35556199 | The transcriptional complexity of the TFIIH complex |
| Q47281234 | Transcription meets DNA repair at a PH domain |
| Q29618407 | p53: puzzle and paradigm |
Search more.